Another email from Leo shared by Wild4ctix this mo
Post# of 72436
"I believe that the $2 share price is the only issue standing in our way to uplist. Our existing agreement with Aspire Capital allows us to meet the capital requirements. Important: It is up to Nasdaq's sole discretion if they will allow us to be on Nasdaq."
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
![Dont-give-up.jpg](https://styleshack.com/wp-content/uploads/2014/07/Dont-give-up.jpg)